In a further step, we evaluated the effect of FOLFOX-treated CAFs on re-transplant ability of isolated colorectal patient tumor CD44v6(+)EpCAM(+)CD133(+)ALDH1(+) cells (CD44v6(+) CICs). The gene discussed is PROM1; the disease is medical procedure.